Whiplash-associated Disorders - Needling Treatments Pilot Study
Unknown statusNot applicableNCT01824810
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
This pilot study is being conducted to provide proof of concept for three recently developed needling treatments, in the treatment of whiplash associated disorder type 2 (WAD-II). The investigators aim to show that these techniques should be considered as regular, effective options for people suffering from WAD-II. These techniques are Intramuscular stimulation (IMS), neural prolotherapy (NPT), and myoActivation (mA). Additionally, the investigators plan to begin profiling responders and non-responders in an effort to identify which treatment is likely to work best for different people. In the future, this may help to expedite treatment for WAD-II, helping patients get the most appropriate treatment, more quickly. The investigators expect to show that all three treatments are significantly better than a placebo treatment, and to collect information on what makes each technique more or less likely to work for individual cases.
Study details
- Official title
- A Pilot Case Randomized Control Study Analysing the Effectiveness of 3 Needling Techniques: Intramuscular Stimulation, Neural Prolotherapy, and Myofascial Release in the Treatment of Chronic Whiplash Associated Disorder.
- Conditions
- Whiplash Injury
- Interventions
- Procedure: Intramuscular Stimulation
- Procedure: myoActivation
- Procedure: Neural Prolotherapy
- Procedure: Sham Needling Control
- Sponsor
- University of British Columbia
- Start date
- 2013-06
- Primary completion
- 2015-12
- Sex
- All
- Age range
- from 19 Years to 75 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Between 19 and 75 years of age * At least 12 months post-trauma * Present with neck and upper back pain (with or without headaches) , matching criteria for WAD-II * Presence of palpable painful points, a necessary indicator that a patient is suitable candidate for treatment Exclusion Criteria: * Widespread pain * History of pre-existing or comorbid chronic pain conditions * Use of anti-coagulants (eg: Coumadin, Warfarin, other prescription anti-coagulants/blood thinners) * Immune deficiency and/or use of immunosuppressants (especially those with splenectomy) * Autoimmune disorders such as lupus or rheumatoid arthritis * HIV, viral hepatitis and other blood borne communicable disease (for practitioner safety) * Local infection around needle insertion site * Fever or systemic infection (cold/flu) * Pregnancy * Unstable bleeding disorders * Less than 6 months post-surgery * Metal implants/screws in the gleno-humeral joint * History of bacterial endocardititis * Heart valve replacement * Past history of any of the proposed needle treatments in the treatment of chronic pain disorders * Needle-based treatment (including any of the treatments in this study, cortisone or botox injection, etc.) for the whiplash injury in the past 3 months
Canadian sites (1)
| Facility | City | Province |
|---|---|---|
| CHANGEpain Clinic | Vancouver | British Columbia |
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01824810